Takagi Seiko
4242.TChemicals
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥23.2bn | ¥22.5bn | ¥23.3bn | ¥19.6bn | ¥19.4bn | ¥17.4bn |
| Operating income | ¥775m | ¥375m | ¥662m | −¥433m | ¥111m | −¥697m |
| Ordinary income | ¥1.8bn | ¥1.2bn | ¥1.7bn | ¥715m | ¥1.1bn | ¥263m |
| Total assets | ¥21.6bn | ¥20.5bn | ¥22.2bn | ¥21.0bn | ¥20.6bn | ¥20.7bn |
| Net assets / equity | ¥8.9bn | ¥6.9bn | ¥8.0bn | ¥6.0bn | ¥5.5bn | ¥4.7bn |
| EPS (basic) | ¥590.96 | ¥-379.24 | ¥616.37 | ¥197.23 | ¥246.28 | ¥-276.48 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 196 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 195 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 195 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 195 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2021-04-01 → 2022-03-31 | AnnualAmended | 195 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 195 figures · EDINET |
25 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| China | ¥6.0bn | −¥154m |
| Japan | ¥23.1bn | ¥834m |
| Southeast Asia | ¥12.4bn | ¥1.5bn |
| Total | ¥41.5bn | ¥2.2bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.